Evidence map›Paper›PMID 32214210›Full record

ArticleScientific reports2020

The First 3D Model of the Full-Length KIT Cytoplasmic Domain Reveals a New Look for an Old Receptor.

François Inizan, Myriam Hanna, Maxim Stolyarchuk, Isaure Chauvot de Beauchêne, Luba Tchertanov

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

François InizanUniversité Paris-Saclay, ENS Paris-Saclay, CNRS, Centre Borelli, 4 avenue des Sciences, F-91190, Gif-sur-Yvette, France.
Myriam Hanna *Université Paris-Saclay, ENS Paris-Saclay, CNRS, Centre Borelli, 4 avenue des Sciences, F-91190, Gif-sur-Yvette, France.
Maxim Stolyarchuk *Université Paris-Saclay, ENS Paris-Saclay, CNRS, Centre Borelli, 4 avenue des Sciences, F-91190, Gif-sur-Yvette, France.
Isaure Chauvot de BeauchêneUniversité de Lorraine, LORIA (CNRS, INRIA), F-54000, Nancy, France.
Luba TchertanovUniversité Paris-Saclay, ENS Paris-Saclay, CNRS, Centre Borelli, 4 avenue des Sciences, F-91190, Gif-sur-Yvette, France. Luba.Tchertanov@ens-paris-saclay.fr.
Université Paris-Saclay · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor tyrosine kinases (RTKs) are key regulators of normal cellular processes and have a critical role in the development and progression of many diseases. RTK ligand-induced stimulation leads to activation of the cytoplasmic kinase domain that controls the intracellular signalling. Although the kinase domain of RTKs has been extensively studied using X-ray analysis, the kinase insert domain (KID) and the C-terminal are partially or fully missing in all reported structures. We communicate the first structural model of the full-length RTK KIT cytoplasmic domain, a crucial target for cancer therapy. This model was achieved by integration of ab initio KID and C-terminal probe models into an X-ray structure, and by their further exploration through molecular dynamics (MD) simulation. An extended (2-µs) MD simulation of the proper model provided insight into the structure and conformational dynamics of the full-length cytoplasmic domain of KIT, which can be exploited in the description of the KIT transduction processes.

Indexed as

Catalytic DomainCytoplasmHumansMolecular Dynamics SimulationProto-Oncogene Proteins c-kitReceptor Protein-Tyrosine KinasesSignal TransductionProto-Oncogene Proteins c-kitReceptor Protein-Tyrosine Kinases

Identifiers

PMID32214210
PMCPMC7096506
OpenAlexW3013563583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.